Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Vyxeos |
|---|---|
| Manufacturer | Jazz Pharmaceuticals plc |
| Prescription required | Yes |
Vyxeos 44mg/100mg Infusionsl sung 1St x 50ml (Daunorubicin and cytarabine)
Daunorubicin and cytarabine
Description
Vyxeos 44mg/100mg Infusionsl sung 1St x 50ml(/) (Daunorubicin and cytarabine) is a medicine catalog record in the MediPriceHub database. Active ingredient: Daunorubicin and cytarabine. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Jazz Pharmaceuticals plc. Therapeutic category: Medicine Library > Oncology Medicines > Leukemia Medicines. Pack information: Vyxeos 44 / 100, 1 x 50. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
VYXEOS is indicated for the treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.How to Use
Jazz Pharmaceuticals Ireland LtdSpecification
Active ingredient: Daunorubicin and cytarabine. Pack size: Vyxeos 44 / 100, 1 x 50. Pack unit: bottle. Manufacturer: Jazz Pharmaceuticals plc. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Leukemia Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.